Product Information
ACARBOSE 25 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.1760 per EA under NDC 64380075806. Its NADAC has been published 649 times since Mar 19, 2014.
FDA first approved this application on Jul 27, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380075806
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACARBOSEApproval Type
Generic (ANDA)
FDA Application
ANDA090912FDA Approved
7/27/2011
TE Code
AB
On Market Since
12/8/2016
Pharmacological Classes
Price Statistics
The NADAC for ACARBOSE 25 MG TABLET has been published 649 times since Mar 19, 2014, and over the history we have for it it has declined 47.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1760 per EA |
|---|---|
| All-time high | $0.3772 (Jun 11, 2014) |
| All-time low | $0.1199 (Nov 20, 2024) |
| 52-week high | $0.1760 |
| 52-week low | $0.1409 |
| Median price | $0.1851 |
| Average price | $0.2086 |
| Largest weekly change | +37.8% (Oct 19, 2022) |
| Weeks tracked | 649 |
| Tracking since | Mar 19, 2014 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ACARBOSE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACARBOSE 25 MG TABLET, manufactured by Strides Pharma Inc., is $0.1760 per EA (NDC 64380075806), effective Aug 19, 2026.
How has the price of ACARBOSE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for ACARBOSE 25 MG TABLET has declined 47.5%. It has been tracked across 649 weekly CMS publications since Mar 19, 2014.
What are the highest and lowest recorded NADAC prices for ACARBOSE 25 MG TABLET?
Since Mar 19, 2014, the NADAC for ACARBOSE 25 MG TABLET has ranged from a low of $0.1199 (Nov 20, 2024) to a high of $0.3772 (Jun 11, 2014), with a median of $0.1851 per EA.
Are there cheaper alternatives to ACARBOSE 25 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ACARBOSE 25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ACARBOSE 25 MG TABLET?
ACARBOSE 25 MG TABLET (NDC 64380075806) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.